Related Experiment Video
Updated: Mar 30, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Potential Microbiological Effects of Higher Dosing of Echinocandins
William J Steinbach1, Frédéric Lamoth2, Praveen R Juvvadi3
1Division of Pediatric Infectious Diseases, Department of Pediatrics Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina.
Abstract:
The antifungal "paradoxical effect" has been described as the reversal of growth inhibition at high doses of echinocandins, most usually caspofungin. This microbiological effect appears to be a cellular compensatory response to cell wall damage, resulting in alteration of cell wall content and structure as well as fungal morphology and growth. In vitro studies demonstrate this reproducible effect in a certain percentage of fungal isolates, but animal model and clinical studies are less consistent. The calcineurin and Hsp90 cell signaling pathways appear to play a major role in regulating these cellular and structural changes. Regardless of the clinical relevance of this paradoxical growth effect, understanding the specific actions of echinocandins is paramount to optimizing their use at either standard or higher dosing schemes, as well as developing future improvements in our antifungal arsenal.
More Related Videos
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Antifungal Agents
Antimicrobial Effectiveness
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Inhibitors of Bacterial Protein Synthesis
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions